325 related articles for article (PubMed ID: 23865457)
1. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
[TBL] [Abstract][Full Text] [Related]
2. Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.
Mangklabruks T; Surachetpong SD
J Vet Cardiol; 2014 Sep; 16(3):155-62. PubMed ID: 25127665
[TBL] [Abstract][Full Text] [Related]
3. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Reimann MJ; Fredholm M; Cremer SE; Christiansen LB; Meurs KM; Møller JE; Häggström J; Lykkesfeldt J; Olsen LH
J Vet Intern Med; 2021 Nov; 35(6):2596-2606. PubMed ID: 34599615
[TBL] [Abstract][Full Text] [Related]
5. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Elliott J
Am J Vet Res; 2012 Nov; 73(11):1765-74. PubMed ID: 23106462
[TBL] [Abstract][Full Text] [Related]
6. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
7. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
8. Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease.
Kim HS; Kang JH; Jeung EB; Yang MP
J Vet Intern Med; 2016 Sep; 30(5):1589-1600. PubMed ID: 27573621
[TBL] [Abstract][Full Text] [Related]
9. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
10. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
Sudunagunta S; Green D; Christley R; Dukes-McEwan J
J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
[TBL] [Abstract][Full Text] [Related]
12. Radial and longitudinal strain and strain rate assessed by speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
Zois NE; Tidholm A; Nägga KM; Moesgaard SG; Rasmussen CE; Falk T; Häggström J; Pedersen HD; Åblad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(6):1309-19. PubMed ID: 23113772
[TBL] [Abstract][Full Text] [Related]
13. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
Reimann MJ; Häggström J; Møller JE; Lykkesfeldt J; Falk T; Olsen LH
J Vet Intern Med; 2017 Mar; 31(2):295-302. PubMed ID: 28132441
[TBL] [Abstract][Full Text] [Related]
14. Serum serotonin concentrations in dogs with degenerative mitral valve disease.
Arndt JW; Reynolds CA; Singletary GE; Connolly JM; Levy RJ; Oyama MA
J Vet Intern Med; 2009; 23(6):1208-13. PubMed ID: 19709352
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease.
Tidholm A; Höglund K; Häggström J; Ljungvall I
J Vet Intern Med; 2015; 29(6):1510-7. PubMed ID: 26365438
[TBL] [Abstract][Full Text] [Related]
16. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
17. Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs.
Ljungvall I; Höglund K; Tidholm A; Olsen LH; Borgarelli M; Venge P; Häggström J
J Vet Intern Med; 2010; 24(1):153-9. PubMed ID: 20002554
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease.
Malcolm EL; Visser LC; Phillips KL; Johnson LR
J Am Vet Med Assoc; 2018 Oct; 253(8):1038-1045. PubMed ID: 30272515
[TBL] [Abstract][Full Text] [Related]
19. The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease.
Höglund K; Häggström J; Höglund OV; Stridsberg M; Tidholm A; Ljungvall I
Acta Vet Scand; 2020 Aug; 62(1):43. PubMed ID: 32758260
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve disease.
Zois NE; Olsen NT; Moesgaard SG; Rasmussen CE; Falk T; Häggström J; Pedersen HD; Møller JE; Olsen LH
J Vet Intern Med; 2013; 27(4):875-83. PubMed ID: 23731222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
